David Colleran
EVP, General Counsel, Corp Sec · 2 filings · Latest: Mar 14, 2026
Anika Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ANIK | David Colleran | EVP, General Counsel, Corp Sec | Mar 15, 2026 | Option Exercise | — | 6,449 | — | 69,463 | |
ANIK | David Colleran | EVP, General Counsel, Corp Sec | Mar 14, 2026 | Option Exercise | — | 9,388 | — | 62,488 | |
ANIK | David Colleran | EVP, General Counsel, Corp Sec | Mar 9, 2026 | Option Exercise | — | 5,465 | — | 55,019 |